| Riyadh Abdulsattar Majeed Al-saffar, MD | |
|
7544 N La Cholla Blvd, Tucson, AZ 85741-2307 | |
| (520) 248-6797 | |
| Not Available |
| Full Name | Riyadh Abdulsattar Majeed Al-saffar |
|---|---|
| Gender | Male |
| Speciality | Student In An Organized Health Care Education/training Program |
| Location | 7544 N La Cholla Blvd, Tucson, Arizona |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750919916 | NPI | - | NPPES |
| Entity Name | Hortensia M Taylor |
|---|---|
| Entity Type | Practitioner - Internal Medicine |
| Entity Identifiers | NPI Number: 1740214246 PECOS PAC ID: 2961427620 Enrollment ID: I20051011001155 |
News Archive
Lukas Kopacki, home from college after the coronavirus pandemic closed his campus, was feeling lousy for days with headaches, sore throat and difficulty breathing through his nose. But he worried that a trip to a doctor's office might make him sicker.
TransPharma Medical Ltd., a specialty pharmaceutical company focused on the development and commercialization of drug products utilizing a proprietary active transdermal drug delivery technology, announced today the successful completion of a Phase 1b trial of ViaDor-GLP1 agonist, which is being developed for the treatment of diabetes mellitus type II.
Cigarette smoking, head injury, farming, pesticide exposure, and a lower level of education may be risk factors for idiopathic rapid eye movement sleep behavior disorder, researchers report.
Gamma Pharmaceuticals, Inc. announced the formation of a joint venture company with Jugular, Inc., replacing the brand licensing agreement in place between Gamma and Jugular since 2007. The new company, Gamma Jugular, LLC is closely integrated with Gamma's existing corporate infrastructure and distribution channels, and currently has three product lines and six SKUs with plans for expansion. Under the terms of the joint venture, Gamma will consolidate Gamma Jugular's performance into Gamma's financials.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Riyadh Abdulsattar Majeed Al-saffar, MD 7544 N La Cholla Blvd, Tucson, AZ 85741-2307 Ph: (520) 742-4564 | Riyadh Abdulsattar Majeed Al-saffar, MD 7544 N La Cholla Blvd, Tucson, AZ 85741-2307 Ph: (520) 248-6797 |
News Archive
Lukas Kopacki, home from college after the coronavirus pandemic closed his campus, was feeling lousy for days with headaches, sore throat and difficulty breathing through his nose. But he worried that a trip to a doctor's office might make him sicker.
TransPharma Medical Ltd., a specialty pharmaceutical company focused on the development and commercialization of drug products utilizing a proprietary active transdermal drug delivery technology, announced today the successful completion of a Phase 1b trial of ViaDor-GLP1 agonist, which is being developed for the treatment of diabetes mellitus type II.
Cigarette smoking, head injury, farming, pesticide exposure, and a lower level of education may be risk factors for idiopathic rapid eye movement sleep behavior disorder, researchers report.
Gamma Pharmaceuticals, Inc. announced the formation of a joint venture company with Jugular, Inc., replacing the brand licensing agreement in place between Gamma and Jugular since 2007. The new company, Gamma Jugular, LLC is closely integrated with Gamma's existing corporate infrastructure and distribution channels, and currently has three product lines and six SKUs with plans for expansion. Under the terms of the joint venture, Gamma will consolidate Gamma Jugular's performance into Gamma's financials.
› Verified 7 days ago